269 related articles for article (PubMed ID: 27093159)
1. Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study.
Ikdahl E; Rollefstad S; Hisdal J; Olsen IC; Pedersen TR; Kvien TK; Semb AG
PLoS One; 2016; 11(4):e0153440. PubMed ID: 27093159
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study.
Ikdahl E; Hisdal J; Rollefstad S; Olsen IC; Kvien TK; Pedersen TR; Semb AG
Arthritis Res Ther; 2015 Oct; 17():279. PubMed ID: 26445924
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
Rollefstad S; Ikdahl E; Hisdal J; Olsen IC; Holme I; Hammer HB; Smerud KT; Kitas GD; Pedersen TR; Kvien TK; Semb AG
Arthritis Rheumatol; 2015 Jul; 67(7):1718-28. PubMed ID: 25778850
[TBL] [Abstract][Full Text] [Related]
4. Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study.
Os HA; Rollefstad S; Gerdts E; Kringeland E; Ikdahl E; Semb AG; Midtbø H
Rheumatology (Oxford); 2020 Dec; 59(12):3700-3708. PubMed ID: 32386421
[TBL] [Abstract][Full Text] [Related]
5. Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies.
Angel K; Provan SA; Hammer HB; Mowinckel P; Kvien TK; Atar D
Fundam Clin Pharmacol; 2011 Aug; 25(4):511-7. PubMed ID: 20825487
[TBL] [Abstract][Full Text] [Related]
6. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
Tam LS; Li EK; Shang Q; Tomlinson B; Lee VW; Lee KK; Li M; Kuan WP; Li TK; Tseung L; Yip GW; Freedman B; Yu CM
Scand J Rheumatol; 2011 Nov; 40(6):411-21. PubMed ID: 21867445
[TBL] [Abstract][Full Text] [Related]
7. Is fatty acid intake a predictor of arterial stiffness and blood pressure in men? Evidence from the Caerphilly Prospective Study.
Livingstone KM; Givens DI; Cockcroft JR; Pickering JE; Lovegrove JA
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1079-85. PubMed ID: 23415455
[TBL] [Abstract][Full Text] [Related]
8. Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases.
Ikdahl E; Wibetoe G; Rollefstad S; Salberg A; Bergsmark K; Kvien TK; Olsen IC; Soldal DM; Bakland G; Lexberg Å; Fevang BTS; Gulseth HC; Haugeberg G; Semb AG
Int J Cardiol; 2019 Jan; 274():311-318. PubMed ID: 30007486
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term statin-treatment on coronary atherosclerosis in patients with inflammatory joint diseases.
Svanteson M; Rollefstad S; Kløw NE; Hisdal J; Ikdahl E; Sexton J; Haig Y; Semb AG
PLoS One; 2019; 14(12):e0226479. PubMed ID: 31830762
[TBL] [Abstract][Full Text] [Related]
10. Degree of arterial stiffness is comparable across inflammatory joint disease entities.
Föhse FK; Rollefstad S; Ikdahl E; Wibetoe G; Sexton J; Hisdal J; Semb AG
Scand J Rheumatol; 2022 May; 51(3):186-195. PubMed ID: 34132621
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis.
Ikdahl E; Rollefstad S; Wibetoe G; Olsen IC; Berg IJ; Hisdal J; Uhlig T; Haugeberg G; Kvien TK; Provan SA; Semb AG
J Rheumatol; 2016 Sep; 43(9):1622-30. PubMed ID: 27307523
[TBL] [Abstract][Full Text] [Related]
12. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
Rollefstad S; Kvien TK; Holme I; Eirheim AS; Pedersen TR; Semb AG
Ann Rheum Dis; 2013 Dec; 72(12):1968-74. PubMed ID: 23264359
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention.
Rollefstad S; Ikdahl E; Hisdal J; Kvien TK; Pedersen TR; Holme I; Semb AG
Ann Rheum Dis; 2015 Aug; 74(8):1544-50. PubMed ID: 24699940
[TBL] [Abstract][Full Text] [Related]
14. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study.
Angel K; Provan SA; Fagerhol MK; Mowinckel P; Kvien TK; Atar D
Am J Hypertens; 2012 Jun; 25(6):644-50. PubMed ID: 22378036
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Arterial Stiffness and Thickness Biomarkers in Type 2 Diabetes Mellitus: An Up-To-Date Meta-Analysis.
Yapei Y; Xiaoyan R; Sha Z; Li P; Xiao M; Shuangfeng C; Lexin W; Lianqun C
Med Sci Monit; 2015 Aug; 21():2467-75. PubMed ID: 26295503
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.
Garg N; Krishan P; Syngle A
Clin Rheumatol; 2015 Jun; 34(6):1065-71. PubMed ID: 25771851
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
[TBL] [Abstract][Full Text] [Related]
20. No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months.
Mathieu S; Pereira B; Couderc M; Rabois E; Dubost JJ; Soubrier M
Rheumatology (Oxford); 2013 Jan; 52(1):204-9. PubMed ID: 23065359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
